Skip to content
Search

Latest Stories

CCA, CPE, and NPA express disappointment over AIMp's clarion call for sector unity

Community Pharmacy England, Company Chemists Association, and the National Pharmacy Association have all expressed their disappointment at a recent press statement made by Dr Leyla Hannbeck, Chief Executive of the Association of Independent Multiple Pharmacies.

The CPE, CCA and NPA refuted AIMp's claim that pharmacy bodies operate independently, emphasising the importance of employing various channels and strategies to shape public policy.


“It makes sense to use a variety of channels and tactics to influence public policy,” NPA, CPE and CCA said in a joint statement issued on Wednesday (August 13).  “Limiting our work to just one Parliamentary channel would be naive and do a disservice to pharmacy owners.”

On Aug. 12, AIMp highlighted that a lack of cohesion was one of the contributing factors to the sector's difficulty in gaining wider attention.

Dr. Hannbeck argued that it's counterproductive for each pharmacy organisation to maintain its own manifesto, essentially a lengthy wish-list that is often unrealistic and unattainable. "This can conveniently allow those in power to easily employ a divide-and-conquer strategy," she said.

Dr. Hannbeck mentioned that the "Save Our Pharmacies" campaign "failed to make a significant impact" and recommended its relaunch by pharmacy bodies through the All Party Pharmacy Group (APPG).

However, CPE, CCA and NPA countered her assertions, emphasising that they maintain a close collaborative effort in influencing both Government and NHS policy through all available channels, with the aim of securing the best possible outcomes for the sector.

"This included our collective efforts to shape the primary care recovery plan, which is set to infuse essential investment into community pharmacy," they said. "We also stand behind the initiatives of the pharmacy APPG since its inception in parliament."

While addressing AIMp's statement, the three organisations emphasised their collaborative capacity, acknowledging that as distinct entities, they may not always share identical perspectives on matters.

They criticised Dr Hannbeck and AIMp for resorting to the media to advocate for unity in the sector instead of engaging in direct dialogue with them.

"We believe that successful collaboration, both within the sector and with external stakeholders, is attained through maintaining open lines of communication and cultivating trusted relationships," the NPA, CPE, and CCA added in their joint statement.

Meanwhile, parliamentarians are set to engage in a crucial debate concerning the future of community pharmacies on Thursday (September 14). This conversation comes at a pivotal juncture, with pharmacies confronting unprecedented challenges such as workforce concerns, medicine supply, and financial pressures.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less